EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand



Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand



Official Gazette of the United States Patent & Trademark Office Patents 1220(4): 3549, March 23




(PDF 0-2 workdays service: $29.90)

Accession: 035980202

Download citation: RISBibTeXText



Related references

Synthesis and receptor binding properties of chimeric peptides containing a mu-opioid receptor ligand and nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-amide. Bioorganic & Medicinal Chemistry Letters 16(18): 4839-4841, 2006

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Molecular Endocrinology 25(10): 1804-1818, 2012

Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9(2): 208-218, 1995

Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking. Journal of Chemical Information and Modeling 48(3): 509-533, 2008

Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor. Fibrinolysis & Proteolysis 12(4): 219-240, July, 1998

Morphological analysis of ligand uptake and processing the role of multivesicular endosomes and compartment of uncoupling of receptor and ligand in receptor ligand processing. European Journal of Cell Biology 36(2): 230-238, 1985

Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988. Food & Chemical Toxicology 37(2-3): 105-110, Feb -March, 1999

Receptor-ligand interaction between vitellogenin receptor and vitellogenin , implications on low density lipoprotein receptor and apolipoprotein B/E The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg. Journal of Biological Chemistry 278(5): 2799-2806, January 31, 2003

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. Molecular Endocrinology 21(1): 30-48, 2007

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. Molecular Endocrinology 21(1): 30-48, 2006

Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling. Biopolymers 41(7): 799-817, 1997

Effects of SH-modifying reagents on the rat hepatic Ah receptor: inhibition of ligand binding and transformation, and disruption of the ligand-receptor complex. Biochimica et Biophysica Acta 964(3): 361-376, 1988

Ligand and receptor dependent sorting of internalized ligand between diacytosis and transport to lysosomes in asialoglycoprotein receptor mediated endocytosis. Journal of Cell Biology 107(6 PART 3): 549A, 1988

The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology 126(1): 371-373, 2004